TIRZEPATIDE SHOTS (ALSO KNOWN AS MOUNJARO)

TIRZEPATIDE ADVANTAGES

• Potent blood sugar control: Tirzepatide effectively lowers blood sugar levels, helping individuals with type 2 diabetes achieve and maintain glycemic control.
• Significant weight loss: Tirzepatide promotes substantial weight loss, making it a valuable option for individuals with obesity or those struggling with weight management alongside diabetes.
• Cardiovascular benefits: Clinical trials have demonstrated that Tirzepatide provides cardiovascular benefits, reducing the risk of major adverse cardiovascular events such as heart attack and stroke.
• Convenient once-weekly dosing: Tirzepatide is available in a once-weekly injectable form, which offers convenience and improves treatment adherence compared to daily medications.
• Potential for comprehensive metabolic treatment: Tirzepatide shows promise for addressing various metabolic issues beyond blood sugar control and weight loss, potentially benefiting individuals with conditions like NAFLD and PCOS.

WHAT YOU NEED TO KNOW ABOUT THE MEDICATION TIRZEPATIDE

• Tirzepatide is one of the newest anti-obesity medications, approved by the FDA in 2021.
• It is classified as a glucagon-like peptide-1 receptor agonist (GLP-1 RA).
• Tirzepatide acts as a dual agonist, targeting GLP-1 and glucagon receptors. This dual action may provide additional benefits regarding glucose regulation, appetite suppression, and weight management.
• Its efficacy in treating type-2 diabetes is attributed to its ability to stimulate insulin production and regulate blood sugar levels.
• Tirzepatide has been found to suppress appetite, making it effective with lifestyle changes such as diet and exercise to aid in weight loss.

ALSO...

"Tirzepatide, sold under the brand name Mounjaro among others, is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections (under the skin). The most common side effects include nausea, vomiting, diarrhea, decreased appetite, constipation, upper abdominal discomfort, and abdominal pain. Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are hormones involved in blood-sugar control. After a person has eaten, these hormones are secreted by cells of the intestines, and in turn cause the secretion of insulin. Tirzepatide is a long-acting GIP-analogue that activates both the GLP-1 and GIP receptors, leading to improved blood-sugar control. Tirzepatide was approved for treatment of diabetes in the United States in May 2022] in the European Union in September 2022, in Canada in November 2022, and Australia in December 2022. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. It was approved by the FDA for weight loss in November 2023, under the brand name Zepbound. In November 2023, the UK Medicines and Healthcare products Regulatory Agency revised the indication for Tirzepatide to include treatment for weight loss".
—SOURCE Wikipedia April 2024

NOTES from Physicians Weight Loss Centers—Pompano Beach

🏥 Lab work will be completed to determine eligibility.

💉The medication is typically administered via weekly subcutaneous injections
under the supervision of healthcare professionals.

🚨Important Advice: Before considering weight loss medications:
Assessment: Get a thorough medical evaluation from a healthcare provider to ensure suitability.
Qualified Review: Have your case reviewed by a healthcare professional to determine eligibility.
Personalized Care: Understand that treatment should be tailored to your needs.
Lifestyle Focus: Remember to combine medication with healthy habits like diet and exercise.
Doctor Supervision: Only use weight loss medications under the supervision of a doctor.

⭐️⭐️⭐️⭐️⭐️

Schedule a complimentary consultation by phone at 954-727-2323 or online today!
...or pass by and visit us at Physicians WEIGHT LOSS Centers — Pompano Beach

Follow us on Instagram for Tips, Tweaks, and Encouragement!